Meliora Therapeutics

Meliora Therapeutics is seed-stage biotech startup leveraging modern genomics and machine learning to discover and develop cancer drugs. In short, the vast majority of cancer drugs fail in clinical trials, and much of the time off-target effects are to blame. We're using sophisticated genomic and machine learning techniques to accurately characterize how drugs affect cells and thereby to develop new drugs more efficiently. Our platform has already surfaced a number of interesting candidate drugs with promising laboratory validation and we are just getting started. Our founding scientist is a faculty member of Yale School of Medicine and our team has strong experience from software/ML through business at Google/Verily/Benchling to complement degrees from MIT/UPenn/Princeton. We are backed by top life science and tech investors. We're looking for talented, ambitious, and creative data scientists and machine learning scientists to join us in building a machine learning-driven cancer drug development engine. Previous experience in biology or computational biology is not required. If you are interested, or you know someone who might be, please reach out via email: david@melioratherapeutics.com